<DOC>
	<DOC>NCT01714297</DOC>
	<brief_summary>The purpose of this study is to determine if there are differences in clinical events, i.e bleeding with associated morbidity, if thromboprophylaxis with LMWH (Low Molecular Weight Heparin) is initiated before or after surgery.</brief_summary>
	<brief_title>Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)</brief_title>
	<detailed_description />
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<criteria>patients 50 years or older undergoing cemented total hip arthroplasty for primary osteoarthritis allergy to LowMolecularWeight Heparin bleeding disorders renal failure hepatic disease active treatment for malignancy history of deep venous thrombosis or pulmonary embolism major operations,trauma,stroke or cardiac infarction the last 3 months before surgery.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>cemented total hip arthroplasty</keyword>
	<keyword>blood loss</keyword>
	<keyword>wound discharge</keyword>
	<keyword>thromboprophylaxis</keyword>
	<keyword>biomarkers</keyword>
</DOC>